henhaobio
Sign in

npj Digital MedicineBioinformaticsPeer-reviewed journal article

Cross-Platform Omics Prediction procedure enables precision medicine in patients with stage-III melanoma

Kevin Y. X. WangiD, Gulietta M. PupoiD, Varsha Tembe, Ellis PatrickiD, Dario StrbenaciD, Sarah‐Jane SchrammiD, John F. ThompsoniD, Richard A. ScolyeriD, Samuel MülleriD, Garth TarriD, Graham J. ManniD, Jean Yee Hwa YangiD

PDFDOIPreprint

Abstract

There is no consensus methodology that can account for the variation in omics signatures when they are acquired across different platforms and times. This poses a significant barrier to the implementation of valuable biomarkers into clinical practice. We present a novel procedure (Cross-Platform Omics Prediction) that accounts for these variations and demonstrate its utility in three risk models for different diseases that is suitable for prospective and multi-centre clinical implementation.

Citations
7
FWCI
0.57
Field percentile
top 43%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.